Talk to Gani about these topics and more:

• Oncology clinical trials (early phase to post approval)
• Oncology medical affairs
• Pharmaceutical, academic and regulatory interactions

Talk to John about these topics and more:

• Tactics for driving health innovation
• Optimizing market access strategies for new therapies
• Demonstrating value through HEOR
• Drug development life cycle strategies

Talk to Tara about these topics and more: 

• Independent Data Monitoring Committees (IDMCs; also known as Data and Safety Monitoring Boards [DSMBs])
• Best practices in clinical data science and biometrics operations
• Clinical trial design and interim analysis
• Biostatistical consulting and regulatory interaction

Talk to Cy about these topics and more:  

• Compliance with human research protection regulations and guidelines  
• IRB member therapeutic and research expertise  
• Demystifying the IRB review process  

Talk to Julie about these topics and more:  

• Human research protection regulations  
• Site operations of clinical research  
• Next-generations IRBs